Search research articles
Contact Us
Filters
Showing results (61-70 of 191) with videos related to
Page
of 20
Sort By:
Neurourology and Urodynamics
|
September 10, 2011
Evaluation of an experimental urodynamic platform to identify treatment effects: a randomized, placebo-controlled, crossover study in patients with overactive bladder
Tara Frenkl, Radha Railkar, Neal Shore, et al.
Clinical Genitourinary Cancer
|
December 26, 2022
A Phase I Study of Capivasertib in Combination With Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer
Neal Shore, Begoña Mellado, Satish Shah, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
June 2, 2026
Real-World Clinical and Economic Outcomes Among Patients with Localized Prostate Cancer Undergoing Radical Prostatectomy Across Different Risk Stratifications in the United States
Neal Shore, Benjamin Lowentritt, Charmi Patel, et al.
Urology
|
March 23, 2022
Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients With Non-Metastatic Castration-Resistant Prostate Cancer
Benjamin Lowentritt, Gordon Brown, Dominic Pilon, et al.
Advances in Therapy
|
August 26, 2022
The Hospitalization-Related Costs of Adverse Events for Novel Androgen Receptor Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: An Indirect Comparison
Neal Shore, Shan Jiang, Viviana Garcia-Horton, et al.
European Urology Oncology
|
May 1, 2025
Association of Deep and Durable Prostate-specific Antigen Responses with Outcomes in Metastatic Hormone-sensitive Prostate Cancer: Insights from ARASENS and ARANOTE Trials
Christopher J D Wallis, Sara Ekberg, Alicia K Morgans, et al.
European Urology
|
August 31, 2014
Efficacy outcomes by baseline prostate-specific antigen quartile in the AFFIRM trial
Fred Saad, Johann de Bono, Neal Shore, et al.
The Journal of Urology
|
May 10, 2024
Reply by Authors
Yair Lotan, Siamak Daneshmand, Neal Shore, et al.
Future Oncology (London, England)
|
March 13, 2020
KEYNOTE-676: Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBC
Ashish M Kamat, Neal Shore, Noah Hahn, et al.
Practical Radiation Oncology
|
September 1, 2023
Barrigel Spacer Injection Technique
Glen Gejerman, Martin M Goldstein, Michael Chao, et al.
Page
of 20
Search research articles
Search
Showing results (61-70 of 191) with videos related to
Sort By:
Page
of 20
Neurourology and Urodynamics
|
September 10, 2011
Evaluation of an experimental urodynamic platform to identify treatment effects: a randomized, placebo-controlled, crossover study in patients with overactive bladder
Tara Frenkl, Radha Railkar, Neal Shore, et al.
Clinical Genitourinary Cancer
|
December 26, 2022
A Phase I Study of Capivasertib in Combination With Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer
Neal Shore, Begoña Mellado, Satish Shah, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
June 2, 2026
Real-World Clinical and Economic Outcomes Among Patients with Localized Prostate Cancer Undergoing Radical Prostatectomy Across Different Risk Stratifications in the United States
Neal Shore, Benjamin Lowentritt, Charmi Patel, et al.
Urology
|
March 23, 2022
Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients With Non-Metastatic Castration-Resistant Prostate Cancer
Benjamin Lowentritt, Gordon Brown, Dominic Pilon, et al.
Advances in Therapy
|
August 26, 2022
The Hospitalization-Related Costs of Adverse Events for Novel Androgen Receptor Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: An Indirect Comparison
Neal Shore, Shan Jiang, Viviana Garcia-Horton, et al.
European Urology Oncology
|
May 1, 2025
Association of Deep and Durable Prostate-specific Antigen Responses with Outcomes in Metastatic Hormone-sensitive Prostate Cancer: Insights from ARASENS and ARANOTE Trials
Christopher J D Wallis, Sara Ekberg, Alicia K Morgans, et al.
European Urology
|
August 31, 2014
Efficacy outcomes by baseline prostate-specific antigen quartile in the AFFIRM trial
Fred Saad, Johann de Bono, Neal Shore, et al.
The Journal of Urology
|
May 10, 2024
Reply by Authors
Yair Lotan, Siamak Daneshmand, Neal Shore, et al.
Future Oncology (London, England)
|
March 13, 2020
KEYNOTE-676: Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBC
Ashish M Kamat, Neal Shore, Noah Hahn, et al.
Practical Radiation Oncology
|
September 1, 2023
Barrigel Spacer Injection Technique
Glen Gejerman, Martin M Goldstein, Michael Chao, et al.
Page
of 20